Astrocytoma Grade Ii
📧 Sign up to get email alerts when something new happens for Astrocytoma Grade Ii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation [Phase 2]
Phase 2 clinical trial update for vorasidenib in pediatric patients with IDH1/IDH2-mutant grade II astrocytoma or oligodendroglioma; the stu…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma [Phase 1]
Phase 1 trial evaluating neo-adjuvant glioma lysate vaccines in WHO Grade II glioma has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
This trial update reports late outcomes from radiotherapy in IDH-mutated gliomas, including astrocytoma grades II and III and oligodendrogli…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) [Phase 1]
Phase 1 trial evaluating varlilumab in combination with the IMA950 vaccine and Poly-ICLC in adults with WHO grade II low-grade glioma; the s…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma [Phase 2]
Phase 2 clinical trial update for FORWARD Optune with adjuvant temozolomide in Grade II/III astrocytoma; study terminated with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.